These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3291258)

  • 1. Cyclosporine-associated encephalopathy in childhood transplant patients.
    Lavenstein B; Stewart C; Tina LU
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):285-7. PubMed ID: 3291258
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of a low-dose two-drug regimen of oral cyclosporine and delayed alternate day prednisone for immunosuppression in cadaver kidney transplantation.
    Belitsky P; MacDonald A; Cohen A; VGivner M; Sketris I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):78-81. PubMed ID: 3291314
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine-associated posttransplant hypertension incidence and effect on renal transplant function.
    Schorn T; Frei U; Brackmann H; Lorenz M; Vogt P; Wiese B; Pichlmayr R; Koch KM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):610-4. PubMed ID: 3291295
    [No Abstract]   [Full Text] [Related]  

  • 4. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine-associated convulsions in a child after renal transplantation.
    Baliga R; Etheredge EE
    Transplantation; 1991 May; 51(5):1126-8. PubMed ID: 2031268
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of nephrotoxic cyclosporine peak concentrations by daily drug division in 3 equal oral portions.
    Zazgornik J; Schindler J; Balcke P; Kopsa H; Gremmel F; Derfler K; Kretschmer G; Mühlbacher F; Piza F
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):197-200. PubMed ID: 3294613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciclosporin in renal transplantation.
    Land W; Castro LA; White DJ; Hillebrand G; Hammer C; Klare B; Fornara P
    Prog Allergy; 1986; 38():293-328. PubMed ID: 3523493
    [No Abstract]   [Full Text] [Related]  

  • 9. One hundred eighty graft biopsies in cyclosporine-treated kidney transplants.
    Yagisawa T; Takahashi K; Toma H; Teraoka S; Yamaguchi Y; Agishi T; Ota K
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):772-6. PubMed ID: 3291312
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporin neurotoxicity in patients treated with allogeneic bone marrow transplantation.
    Labar B; Bogdanic V; Plavsic F; Francetic I; Dobric I; Kastelan A; Grgicevic D; Vrtar M; Grgic-Markulin L; Balabanic-Kamauf B
    Biomed Pharmacother; 1986; 40(4):148-50. PubMed ID: 3539218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is cyclosporine-induced chronic nephrotoxicity inevitable?
    Scolari F; Sandrini S; Savoldi S; Cristinelli L; Brunori G; Prati E; Sacchi G; Tardanico R; Cancarini GC; Maiorca R
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1745-8. PubMed ID: 3824506
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporin neurotoxicity presenting as an unilateral foot drop in a renal transplant patient.
    Patel MK; Rashed A; Mesraoua B; Khaddash S; Romeh SA
    Nephron; 1991; 58(1):116. PubMed ID: 1857469
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective serial renal function studies in patients with nonrenal disease treated with cyclosporine A.
    Tegzess AM; Doorenbos BM; Minderhoud JM; Donker AJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):530-3. PubMed ID: 3388497
    [No Abstract]   [Full Text] [Related]  

  • 14. An interim analysis of the on-going long-term safety study of cyclosporine in renal transplantation.
    Cockburn I; Götz E; Gülich A; Krupp P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):519-29. PubMed ID: 3291290
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporin-induced renal magnesium leak in renal transplant patients.
    Scoble JE; Freestone A; Varghese Z; Fernando ON; Sweny P; Moorhead JF
    Nephrol Dial Transplant; 1990; 5(9):812-5. PubMed ID: 2129356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function in a newborn baby delivered of a renal transplant patient taking cyclosporine.
    Klintmalm G; Althoff P; Appleby G; Segerbrandt E
    Transplantation; 1984 Aug; 38(2):198-9. PubMed ID: 6380049
    [No Abstract]   [Full Text] [Related]  

  • 17. [Side effects of cyclosporin following kidney transplantation and in patients with autoimmune diseases].
    von Graffenried B; Krupp P
    Internist (Berl); 1985 Sep; 26(9):542-8. PubMed ID: 3905674
    [No Abstract]   [Full Text] [Related]  

  • 18. Tubular vacuolization in kidney graft biopsies in different cyclosporine protocols.
    Hedman L; Svalander C
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):722-4. PubMed ID: 3291307
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical renal transplantation: exfoliative urinary cytology in the evaluation of nephrotoxicity induced by cyclosporin therapy].
    Stella F; Alfani D; Renna Molajoni E; Rossi M; Rossi Lemeni A; Stella C; Di Tondo U; Troccoli R; Cortesini R
    Quad Sclavo Diagn; 1984 Sep; 20(3):295-303. PubMed ID: 6397762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation.
    Savoldi S; Scolari F; Sandrini S; Scaini P; Sacchi G; Tardanico R; Camerini C; Salerni B; Tonini G; De Nobili U
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):777-84. PubMed ID: 3291313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.